Clinical trial finds an increased risk of blood clots in the lungs and of death in rheumatoid arthritis patients taking high dose of tofacitinib (sold as Xeljanz or Xeljanz XR)

March 15, 2019For immediate release OTTAWA – Health Canada is conducting a safety review after issues were discovered during a

Read more